Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).
about
Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma.Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer.Targeted therapies for gastric cancer: current status.S-1-based therapy versus S-1 monotherapy in advanced gastric cancer: a meta-analysis.A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer.Recent developments in the systemic therapy of advanced gastroesophageal malignancies.Chemotherapy for gastric cancer.Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil.Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancerPhase II study of S-1 in patients with advanced biliary tract cancer.Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results.Chemotherapy for advanced gastric cancer: review of global and Japanese status.Upper gastrointestinal tumors: current status and future perspectives.Chemotherapy for advanced gastric cancer: slow but further progress.A multi-center, phase ii clinical trial of Padexol (paclitaxel) and cisplatin for patients suffering with advanced gastric cancer.Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer.A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.Metastatic gastric cancer treatment: a little slow but worthy progress.S-1 (Teysuno®): a review of its use in advanced gastric cancer in non-Asian populations.Emerging tyrosine kinase inhibitors for esophageal cancer.Emerging mAbs for the treatment of esophagogastric cancer.Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma.Recent Developments in Cytotoxic Therapy for Advanced Gastric or Gastroesophageal Carcinoma: The Phase III TrialsS-1 plus oxaliplatin vs. S-1 as first-line treatment in patients with previously untreated advanced gastric cancer: a randomized phase II study.Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer.Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS).Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 cases.Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group.
P2860
Q33366682-C674DFBF-E3B1-46CC-B42E-44A821E750AEQ33371306-5468FF7B-388E-411F-9233-88C8C5194244Q33391384-20972956-A97C-40AE-B446-6578204B0AA4Q33410008-252AF9A9-7D30-47F4-833C-EDA98478E664Q33566877-2F0FFBCB-7838-47BF-8804-56263DE3753BQ34205672-7041B496-4065-4328-83C2-2A422E8B98CAQ35081966-EF63CE55-7BB7-41B2-8FBB-08C4927BD9F4Q35612770-D9E276FA-4029-4B08-8CC6-529A20EA6B41Q36376439-7371B003-F60A-4E10-B5BA-BF5CFA41ED73Q36398226-4BA5A7E0-822E-4561-B7B9-0038A1EACA1EQ36612612-436F46A4-10E1-4FA3-8F8E-5FA2E0605ADEQ36614394-DF1BF42A-2A82-46B4-BF78-5832DF2BD5BAQ36615597-E47763BB-3410-4DC4-ACF6-10F402B16DC7Q36671793-F2AB3B3B-CE26-4D0A-A50A-8AA178B92532Q36673543-EDDA2EA1-7ADB-4CF9-9F88-48E7F9CD794CQ36696249-10129119-B725-4402-AA94-3A9D658FAFE5Q36822873-2C6D2E96-A177-41BE-ABC3-E34F8EE4C21FQ37076553-B1643EAF-13C2-4B75-AD0B-2376969B0CF2Q37183479-4D1B6B0E-6637-477B-A8F0-8167D5F696DEQ37446941-C3550B9C-CE2D-4B21-80C0-29FDF7964F7EQ37449306-8FDFC9D2-0563-4149-8F95-66ADDB3A9E74Q37561374-122D8BE9-A959-465D-AE9D-2DA599C83722Q37780473-6BD4BBD8-767C-410C-8304-44912DF8E544Q37889959-659EBA9F-0BE0-4F66-B06A-5E9C2C3DC6CEQ38075499-39947ACF-3B1A-405D-BA02-5E88960C211CQ38110441-84C311A0-B04E-40B7-8A72-1109A6BADC5DQ38110962-67692308-2FB8-4045-9C9D-14BE55AE906EQ38284597-537B5520-DB1E-4638-8885-57CE6F7893CAQ40725730-FCA1DBAB-1198-4B0D-9874-686AADD9DE73Q42181610-4E369010-B744-4F74-9006-2C7B7AB20F92Q44064732-59D6F837-E687-4A52-8851-165902EC8B53Q44150769-DCD2678A-E3EF-45D6-AF4C-B5C913E6AC5BQ45435712-17510759-C0DF-4C7F-9F14-2ACE3F8459B4Q46822414-8EAEA1ED-1727-48EB-85B9-93F137091F44Q46828997-D051F378-ABEB-473E-9717-26F4604AEB47Q48048391-BD607D6C-9F24-46C4-B132-DEE0A215829CQ50919741-D2BA13F4-6254-44BB-9A0F-1DDE470826B8Q53374544-06B1B383-1DC2-4945-B240-41379BBB6BDD
P2860
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@ast
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@en
type
label
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@ast
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@en
prefLabel
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@ast
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@en
P2093
P1476
Phase II trial with S-1 in che ...... Clinical Studies Group (ECSG).
@en
P2093
EORTC Early Clinical Studies Group
J H M Schellens
K Weigang-Köhler
N Pavlidis
P Fumoleau
P Schöffski
P304
P356
10.1016/S0959-8049(03)00237-5
P577
2003-06-01T00:00:00Z